Nonmotor Symptoms in Amyotrophic Lateral Sclerosis and Their Correlation With Disease Progression
Objectives: Motor neuron disease is a progressive neurodegenerative disease involving upper and lower motor neurons. Nonmotor symptoms (NMS) are part of disease manifestation. We aim to report the prevalence and severity of NMS in patients with motor neuron disease (MND) in Lebanon.  Methods: Fifty-eight patients diagnosed with MND at the American University of Beirut Medical Center were interviewed using the NMS Scale. The prevalence of these symptoms was assessed and correlated with disease progression. Results: All our patients had at least 2 NMS with an average total score of 15.8. Symptom...
Source: Journal of Clinical Neuromuscular Disease - August 28, 2021 Category: Neurology Tags: Original Article Source Type: research

A Cerner Real-World Data Study of Spinal Muscular Atrophy Patients With Positive COVID-19 Infection
No abstract available (Source: Journal of Clinical Neuromuscular Disease)
Source: Journal of Clinical Neuromuscular Disease - May 27, 2021 Category: Neurology Tags: Letters to the Editor Source Type: research

Sensory Neuronopathy Postbariatric Surgery, Beyond Nutritional Deficiency
No abstract available (Source: Journal of Clinical Neuromuscular Disease)
Source: Journal of Clinical Neuromuscular Disease - May 27, 2021 Category: Neurology Tags: Letters to the Editor Source Type: research

Postsurgical Inflammatory Sciatic Neuropathy
No abstract available (Source: Journal of Clinical Neuromuscular Disease)
Source: Journal of Clinical Neuromuscular Disease - May 27, 2021 Category: Neurology Tags: Letters to the Editor Source Type: research

Effect of Focal Traumatic Injury in Nondystrophic Myotonic Disorders
No abstract available (Source: Journal of Clinical Neuromuscular Disease)
Source: Journal of Clinical Neuromuscular Disease - May 27, 2021 Category: Neurology Tags: Letters to the Editor Source Type: research

Aphasia and Weakness in a Child Think Beyond Stroke
No abstract available (Source: Journal of Clinical Neuromuscular Disease)
Source: Journal of Clinical Neuromuscular Disease - May 27, 2021 Category: Neurology Tags: Letters to the Editor Source Type: research

Type 2 Antineuronal Nuclear Antibody in Nontumor Lambert–Eaton Myasthenic Syndrome: A Rare Association With Clinical Implications
No abstract available (Source: Journal of Clinical Neuromuscular Disease)
Source: Journal of Clinical Neuromuscular Disease - May 27, 2021 Category: Neurology Tags: Letters to the Editor Source Type: research

A Case of Elsberg Syndrome in the Setting of Asymptomatic SARS-CoV-2 Infection
We report here, to the best of our knowledge, the first case of suspected COVID-19–associated Elsberg syndrome, which expands the spectrum of neuromuscular manifestations associated with SARS-CoV-2 infection and sheds light on ways to approach diagnostic and treatment options for these patients. (Source: Journal of Clinical Neuromuscular Disease)
Source: Journal of Clinical Neuromuscular Disease - May 27, 2021 Category: Neurology Tags: Short Report Source Type: research

Glycogen Debrancher Enzyme Deficiency Myopathy
We report on a patient with myopathy due to glycogen storage disease III, and describe the clinical features, and pathologic and genetic findings. (Source: Journal of Clinical Neuromuscular Disease)
Source: Journal of Clinical Neuromuscular Disease - May 27, 2021 Category: Neurology Tags: Short Report Source Type: research

I Want to Row Across the Atlantic. But You Have Amyotrophic Lateral Sclerosis!
We describe an individual with slowly progressive amyotrophic lateral sclerosis who decided to enter the Talisker Whisky Atlantic Challenge, a rowing event across the Atlantic Ocean, and completes it in 51 days in a 5-man boat. (Source: Journal of Clinical Neuromuscular Disease)
Source: Journal of Clinical Neuromuscular Disease - May 27, 2021 Category: Neurology Tags: Case Review Source Type: research

Rituximab Treatment for Chronic Idiopathic Axonal Polyneuropathy
We describe 2 cases of chronic idiopathic axonal polyneuropathy who received intravenous rituximab as a last resort because of the severity of their symptoms. Both patients showed dramatic improvement in their weakness, muscle atrophy, numbness, and paresthesias only few weeks after the induction dose. Their daily functional activities improved to self-independence. (Source: Journal of Clinical Neuromuscular Disease)
Source: Journal of Clinical Neuromuscular Disease - May 27, 2021 Category: Neurology Tags: Case Review Source Type: research

Variant Median Nerve Anatomy: Ultrasound Evidence of a Pseudoconduction Block
Conclusions: This case demonstrates that neuromuscular ultrasound may supplement the electrodiagnostic study and limit confounding technical factors because of rare anatomic variation. (Source: Journal of Clinical Neuromuscular Disease)
Source: Journal of Clinical Neuromuscular Disease - May 27, 2021 Category: Neurology Tags: Case Review Source Type: research

What is in the Literature
This edition of What is in the Literature focuses on chronic immune neuropathies as they represent treatable conditions. There are formal criteria to solidify the diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), but patients are encountered who have clinical and electrodiagnostic features of CIDP but do not fulfill diagnostic criteria. These patients are addressed in recent publications. CIDP (and variants) and other forms of immune-mediated neuropathies (multifocal motor neuropathy) are responsive early on to treatment, but long-term factors are less well described, and a number of publicatio...
Source: Journal of Clinical Neuromuscular Disease - May 27, 2021 Category: Neurology Tags: Review Article Source Type: research

Clinical Features and Treatment Response in Immune-Mediated Small Fiber Neuropathy with Trisulfated Heparin Disaccharide or Fibroblast Growth Factor Receptor 3 Antibodies
Conclusions: TS-HDS and FGFR-3 antibodies may be present in a high proportion of cryptogenic SFN cases with acute onset, nonlength dependent pathology, and primary neuropathic and widespread pain. They are often misdiagnosed as other conditions including fibromyalgia. These cases may be responsive to immune treatment, especially with intravenous immunoglobulin. (Source: Journal of Clinical Neuromuscular Disease)
Source: Journal of Clinical Neuromuscular Disease - May 27, 2021 Category: Neurology Tags: Original Article Source Type: research

Readmissions After Guillain–Barre Syndrome: Nationally Representative Data
Conclusions: One-fifth of GBS patients were readmitted within 1 year. Comorbid illnesses and respiratory complications increased a readmission risk but age did not. (Source: Journal of Clinical Neuromuscular Disease)
Source: Journal of Clinical Neuromuscular Disease - May 27, 2021 Category: Neurology Tags: Original Article Source Type: research